ARTICLE | Finance
Hope for China’s academic spinouts
How professors are joining China’s drive toward innovative biotech
April 19, 2019 11:33 PM UTC
Peking University spinout Hope Medicine is one of the latest examples of a trend that sees academics from Chinese universities increasingly taking top roles in a biotech sector traditionally led by MNC veterans.
The start-up launched early this month with a deal with Bayer AG (Xetra:BAYN), a $26 million series A round from Trustbridge Partners and Chinese PE firm Qi Rui You Kang, and Peking University Institute of Molecular Medicine professor Rui-Ping Xiao as co-founder, chairman and CEO...